Krebs Biochemicals & Industries Ltd - KREBS BIOCHEM Share Price

Sector: Pharmaceuticals | ISIN: INE268B01013
₹ 71.40 (1.20%) icon12 Apr, 2024, 12:00:00 AM

Krebs Biochemicals & Industries Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/12/2024 12:00:00 AM

    ₹ 71.4 0.85 1.20
  • Open
  • ₹ 73.4
  • Prev. Close
  • ₹ 70.55
  • Turnover(Lac.)
  • ₹ 2
  • Day's High
  • ₹ 73.4
  • Day's Low
  • ₹ 70.1
  • 52 Week's High
  • ₹ 93.95
  • 52 Week's Low
  • ₹ 59.2
  • Book Value
  • ₹ -52.57
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 153.94
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Krebs Biochemicals & Industries Ltd Corporate Actions

19 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jan , 2024

12:00 AM

17 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Oct , 2023

12:00 AM

09 Aug , 2023

12:00 AM

AGM

Announcement date: 09 Aug , 2023

View Details

21 Jul , 2023

12:00 AM

21 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Sep , 2023

12:00 AM

BookCloser

View Details

12 Sep , 2023

12:00 AM

BookCloser

View Details

No Record Found


Krebs Biochemicals & Industries Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Krebs Biochemicals & Industries Ltd SHAREHOLDING SNAPSHOT
14 April , 2024 | 12:54 PM

PROMOTER - TOTAL72.74%

Indian: 72.74%

Foreign: 0%

NON-PROMOTER - TOTAL 27.26%

Institutions: 0.50%

Non-Institutions: 26.76%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Krebs Biochemicals & Industries Ltd FINANCIALS

No Data Available To Display Chart

Krebs Biochemicals & Industries Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Krebs Biochemicals & Industries Ltd

  • G V L Prasad
  • Independent Director
  • R T Ravi
  • Chairman (Non-Executive)
  • Avinash Ravi
  • Non Executive Director
  • Tangirala Malati
  • Independent Director
  • Satish Khivsara
  • Independent Director
  • Raj Kamal Prasad Verma
  • Independent Director
  • Rohit Taparia
  • Company Sec. & Compli. Officer
  • Jitendra Shah
  • Managing Director

Summary

Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process. The Company commissioned 2.5 MW Co-generation Power Plant at Unit II in Vizag during 2003-04 and started operations on it from July, 2004... Read More


Reports by Krebs Biochemicals & Industries Ltd


Reports by Krebs Biochemicals & Industries Ltd

Company FAQ

No Record Found